IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
29.42
-0.05 (-0.17%)
Jun 1, 2026, 12:44 PM EDT - Market open
IDEAYA Biosciences Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, IDEAYA Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $51.69. The average 1-year stock price forecast is 75.70% higher than the current stock price, while the lowest is $36 (+22.37%) and the highest is $66 (+124.34%).
Price Target: $51.69 (+75.70%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IDEAYA Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 14 | 13 | 13 | 13 | 13 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 19 | 18 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $81 → $66 | Buy | Maintains | $81 → $66 | +124.34% | May 29, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $62 | Buy | Maintains | $62 | +110.74% | May 10, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $52 → $50 | Buy | Maintains | $52 → $50 | +69.95% | May 6, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $53 | Buy | Maintains | $53 | +80.15% | May 6, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $65 | Buy | Reiterates | $65 | +120.94% | May 6, 2026 |
Financial Forecast
Revenue This Year
27.94M
from 218.71M
Decreased by -87.23%
Revenue Next Year
114.59M
from 27.94M
Increased by 310.17%
EPS This Year
-4.42
from -1.28
EPS Next Year
-4.01
from -4.42
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 65.7M | 180.3M | ||||||
| Avg | 27.9M | 114.6M | ||||||
| Low | n/a | 58.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -69.9% | 545.5% | ||||||
| Avg | -87.2% | 310.2% | ||||||
| Low | - | 110.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -3.84 | -2.93 | ||||||
| Avg | -4.42 | -4.01 | ||||||
| Low | -4.81 | -4.50 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.